Font Size:
a
A
A
Keyword [Molecular dynamics simulations]
Result: 41 - 60 | Page: 3 of 3
41.
Design Of S6K1 Inhibitors By Molecular Docking And Molecular Dynamics Simulations
42.
Molecular Dynamics Simulations On Structure And Function Of The Saccharomyces Cerevisiae Ssa1 N-terminal Domain
43.
Molecular Dynamics Simulation On Key Residue Mutations Of The S4 Pocket Of Coagulation Factor X
44.
Study On The Interaction And The Mechanism Of Mechanical Regulation Between The Transmembrane Proteins(PSGL-1,CD40l) With Receptors That Mediate The Immune Response Of Circulating Leukocytes
45.
Molecular dynamics simulations of negatively charged lipid bilayers and the distribution of an environmental pollutant in lipid bilayers
46.
Exploring DNA Damage and Repair through Molecular Dynamics Simulations
47.
1alpha,25-dihydroxyvitamin D3 Agonist and Histone Deacetylase Inhibitor Bifunctional Ligand Discovery Virtual Docking, Synthesis, Fluorescence Polarization-Based Screening, and Molecular Dynamics Simulations
48.
Characterization of Familial Amyotrophic Lateral Sclerosis Associated Mutants of the Human CopperZinc Superoxide Dismutase Monomer by Molecular Dynamics Simulations
49.
Study On Molecular Dynamics Simulations Of Key Enzyme PhzF And PhzG In Biosynthetic Pathway And Qsar Of Phenazine Antibiotics
50.
Molecular Dynamics Simulations Study On The Allosteric Regulation Mechanism Of Protein Tyrosine Phosphatase PTP1B And SHP2
51.
Studying The Effect Of Albumin On The Structure Of Amyloid-β Peptide With Molecular Dynamics Simulations
52.
Discovery Of A Novel XO Inhibitor Through Molecular Docking-Based Virtual Screening And Molecular Dynamics Simulation Studies
53.
Molecular Dynamics Simulations Explore The Interactions Between Different Inhibitors And Xanthine Oxidase
54.
Molecular Docking,3D-QSAR And Molecular Dynamics Simulation Of Mps1 Inhibitors
55.
Drug Studies Of GCGR And SMO Targets
56.
Molecular Dynamics Simulation And Network Pharmacology To Study The Mode Of Action Of Alzheimer’s Disease-associated Proteins With Different Ligands
57.
To Explore The Interactions Between Lysine Specific Demethylase 1 And Inhibitors Using Molecular Dynamics Simulations
58.
Discovery Of Potential RIPK1 Inhibitors By Machine Learning And Molecular Dynamics Simulations
59.
Molecular Dynamics Simulation Of Different Binding Patterns Of Bromodomain-containing Protein 4 To Potent Inhibitors
60.
The Mechanism Of Abnormal Activation Of MEK1 Induced By Dehydroalanine Modification And The Effect Of FDA-Proved Inhibitors
<<First
<Prev
Next>
Last>>
Jump to